Regulations.gov document
NDI 837- 1,6-bis [L-phenylalanin-N-alpha-amino] hexanediamide from Smith-Ennismore…
Other · FDA-2014-S-0023 · posted Jan 22, 2015
Key facts
| Document ID | FDA-2014-S-0023-0062 |
|---|---|
| Title | NDI 837- 1,6-bis [L-phenylalanin-N-alpha-amino] hexanediamide from Smith-Ennismore Industries Limited |
| Document type | Other |
| Subtype | 75 Day PreMarket Notification |
| Agency | FDA |
| Docket | FDA-2014-S-0023 |
| Posted | Jan 22, 2015 |
| Comment period opens | Jan 22, 2015 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: